299 related articles for article (PubMed ID: 22560134)
1. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of bullous pemphigoid.
Ujiie H; Nishie W; Shimizu H
Dermatol Clin; 2011 Jul; 29(3):439-46, ix. PubMed ID: 21605809
[TBL] [Abstract][Full Text] [Related]
3. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
[TBL] [Abstract][Full Text] [Related]
4. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
5. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
7. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
8. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
9. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.
Yamamoto K; Inoue N; Masuda R; Fujimori A; Saito T; Imajoh-Ohmi S; Shinkai H; Sakiyama H
J Invest Dermatol; 2002 Mar; 118(3):485-92. PubMed ID: 11874488
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
Nishie W
Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
[TBL] [Abstract][Full Text] [Related]
11. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
12. Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.
Messingham KN; Randall G; Fairley J
G Ital Dermatol Venereol; 2016 Apr; 151(2):186-97. PubMed ID: 26959553
[TBL] [Abstract][Full Text] [Related]
13. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
14. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
Nishie W
J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
[TBL] [Abstract][Full Text] [Related]
15. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
16. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
van Beek N; Schulze FS; Zillikens D; Schmidt E
Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of a cDNA encoding the porcine type XVII collagen noncollagenous 16 A domain and localization of the domain to the upper part of porcine skin basement membrane zone.
Xu L; Olivry T; Chan LS
Vet Dermatol; 2004 Jun; 15(3):146-51. PubMed ID: 15214950
[TBL] [Abstract][Full Text] [Related]
18. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
Ujiie H
J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
[TBL] [Abstract][Full Text] [Related]
19. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid.
Nishie W; Lamer S; Schlosser A; Licarete E; Franzke CW; Hofmann SC; Jackow J; Sitaru C; Bruckner-Tuderman L
J Immunol; 2010 Oct; 185(8):4938-47. PubMed ID: 20861347
[TBL] [Abstract][Full Text] [Related]
20. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
Leighty L; Li N; Diaz LA; Liu Z
Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
